Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
+28.8%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 28.46% |
| 2024 | 97.02% |
| 2023 | 425.83% |
| 2022 | 13.31% |
| 2021 | -73.44% |
| 2020 | 0.00% |
| 2019 | 0.00% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |